Having trouble viewing this e-mail? CLICK HERE

Pharmtech
April 2019
Volume 31, No. 4
VIEW ONLINE ARCHIVE SUBSCRIBE FORWARD Twitter LinkedIn
advertisement

| COVER STORY |

Patient-Centric Drug Development Comes of Age

Felicity Thomas

Easier access to information, targeting smaller patient populations, and increased regulatory focus on patient outcomes are driving patient‑centric drug development.
/ read more /


| API SYNTHESIS AND MANUFACTURING |

Select Suppliers with Demonstrated Expertise to Avoid Sourcing "Bad" APIs

Cynthia A. Challener

Confidence in the quality systems and scientific competence of the API manufacturing team is essential.
/ read more /


| DRUG DELIVERY |

Advanced Cell Penetrating Peptide System for Gene Therapy

Lyndsey Johnson, James E. Dixon, and Kevin M. Shakesheff

Intracellular strategies offer an effective alternative approach to deliver a range of therapeutic proteins.
/ read more /


PharmTech Europe April Issue
Read the issue online Subscribe or renew your Pharm Tech subscription

advertisement

| PEER-REVIEWED RESEARCH |

Degradation Pathways: A Case Study with Pegylated L-Asparaginase

Chintan Patel, Sanjay Bandyopadhyay, and Gayatri C. Patel

In this article, the effect of freeze-thawing and high temperature on the stability of pegaspargase protein was studied. Differences in the degradation pathways for the storage conditions were identified, and manufacturing issues associated with the degradation are discussed.
/ read more /


| CLEANING PROCESS |

Cleaning Chromatography Resin Residues from Surfaces

Elizabeth Rivera and Dijana Hadziselimovic

Laboratory test methods evaluate cleaning agents and cleaning process design for non-dedicated chromatography columns systems.
/ read more /


| CONTINUOUS MANUFACTURING |

OSD Continuous Manufacturing Strategies

Jennifer Markarian

Flexible batch sizes can optimize supply, but equipment processing challenges are still being addressed.
/ read more /


| ANALYTICS |

Particles on Best Behaviour

Felicity Thomas

Characterizing particles and understanding bulk powder behaviour is critical to get the best pharma product.
/ read more /


| OPERATIONS |

Technology Transfer: Best Practices in Operational Development

Derek Gallo and Sanjay Konagurthu

Successful technology transfer depends on the ability to anticipate risks and plan ahead.
/ read more /


| EDITOR'S COMMENT |

Doing the Brexit Hokey Cokey?

Felicity Thomas

Uncertainty remains around the UK's departure from the EU, potentially causing irreparable damage to the bio/pharma sector.
/ read more /


| EUROPEAN REGULATORY WATCH |

Regulating Pharmaceuticals in the Environment

Sean Milmo

The European Commission has published a strategy that will form the basis for the European Union's policy on pharmaceuticals in the environment.
/ read more /


| ASK THE EXPERT |

Channelling Customer Complaints into Quality

Susan J. Schniepp

A robust customer complaint handling system is an integral part of a quality management system, says Susan Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
/ read more /



| EVENTS |

APACT '19

Chester, UK
30 April–2 May 2019

RAPS Regulatory Conference Europe 2019

Brussels, Belgium
13–14 May 2019

Injectable Drug Delivery 2019

London, UK
15–16 May 2019

more events

Contribute an article | contact the editors | contact sales | subscribe | advertise